Invivoscribe 12-Color Flow Cytometry Service

Invivoscribe has launched a 12-color multiparametric flow cytometry (MFC) service in Shanghai, China, the newest reference laboratory in the company's international LabPMM network. The company noted that it can now offer the combination of 12-color flow cytometry and next-generation sequencing (NGS) minimal residual disease assessment in blood cancers out of its labs in the US, Europe, and China. The addition of 12-color MFC to NGS eliminates the need to split primary subject specimens and have them tested in multiple labs, Invivoscribe said. It also allows the same pull of bone marrow to be tested using complementary technologies, so pharma partners can compare results from limited samples using targeted assays for drug development and clinical studies, the company noted.